About BaroFold
BaroFold is a company based in Aurora (United States) founded in 2003 by Matthew Seefeldt and Matt Brewer was acquired by Pressure BioSciences in December 2017.. BaroFold has raised $16.35 million across 4 funding rounds from investors including HBM Healthcare Investments, Pressure BioSciences and Boulder Ventures. BaroFold offers products and services including Barocycler 2320EXT and BaroShear TM K45. BaroFold operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter Aurora, United States
- Founders Matthew Seefeldt, Matt Brewer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pressure Biosciences, Inc.
-
Annual Revenue
$1.98 M14as on Dec 31, 2023
-
Net Profit
$-29.31 M-82as on Dec 31, 2023
-
EBITDA
$-9.5 M-94as on Dec 31, 2023
-
Total Equity Funding
$16.35 M (USD)
in 4 rounds
-
Latest Funding Round
$1.7 M (USD), Series A
Feb 20, 2013
-
Investors
HBM Healthcare Investments
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Pressure BioSciences
(Dec 13, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BaroFold
BaroFold offers a comprehensive portfolio of products and services, including Barocycler 2320EXT and BaroShear TM K45. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Compact instrument for processing biological samples using high pressure.
System for preparing high-quality nanoemulsions of substances like CBD oil.
Unlock access to complete
Funding Insights of BaroFold
BaroFold has successfully raised a total of $16.35M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.7 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $1.7M
-
First Round
First Round
(29 May 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2013 | Amount | Series A - BaroFold | Valuation |
investors |
|
| Aug, 2012 | Amount | Series A - BaroFold | Valuation |
investors |
|
| Feb, 2010 | Amount | Series A - BaroFold | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BaroFold
BaroFold has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HBM Healthcare Investments, Pressure BioSciences and Boulder Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Founded Year | Domain | Location | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Founded Year | Domain | Location | |
|
Biomolecular reactions are controlled via pressure cycling technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BaroFold
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BaroFold
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Barofold Comparisons
Competitors of BaroFold
BaroFold operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BaroFold
When was BaroFold founded?
BaroFold was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Where is BaroFold located?
BaroFold is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Who is the current CEO of BaroFold?
Matt Brewer is the current CEO of BaroFold. They have also founded this company.
Is BaroFold a funded company?
BaroFold is a funded company, having raised a total of $16.35M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.2M, raised on May 29, 2007.
What is the annual revenue of BaroFold?
Annual revenue of BaroFold is $1.98M as on Dec 31, 2023.
What does BaroFold do?
BaroFold was established in 2003 in Aurora, United States, as a biopharmaceutical entity focused on immunology. Protein therapeutics are developed and commercialized using proprietary PreEMT high-pressure folding technology alongside other advanced methods. The pipeline targets conditions such as Multiple Sclerosis, Rheumatoid Arthritis, and Asthma, with operations centered on therapeutic innovation in the immunology sector.
Who are the top competitors of BaroFold?
BaroFold's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
What products or services does BaroFold offer?
BaroFold offers Barocycler 2320EXT and BaroShear TM K45.
Who are BaroFold's investors?
BaroFold has 3 investors. Key investors include HBM Healthcare Investments, Pressure BioSciences, and Boulder Ventures.